Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LarreaRx
San Diego, California, United Stateslarrearx.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
LarreaRx is a biotechnology company focused on developing and commercializing therapeutic products derived from the Larrea tridentata (creosote bush) plant. The company utilizes a proprietary extraction process to isolate Nordihydroguaiaretic acid (NDGA) and other lignans known for their potent antiviral and anti-inflammatory properties. LarreaRx offers a range of over-the-counter (OTC) topical and oral formulations designed to manage viral outbreaks such as herpes simplex and shingles, as well as chronic skin conditions like psoriasis. Their business model combines direct-to-consumer sales with ongoing research into the broad-spectrum applications of Larrea-based compounds in modern medicine.
- Therapeutic areas
- DermatologyInfectious Diseases
- Modalities
- Small moleculePlant-derived extract
- Industry
- Biotech
Beyond the preview
Go deeper on LarreaRx.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LarreaRx.